Riktkurs.nu
EN | SV
Stockholm Stock Exchange
Sobi
+9.52% (40.00)
+14.29% (60.00)
Pareto SecuritiesBerenbergNordeaSEBBarclaysExane BNP ParibasDeutsche BankDNB CarnegieABG Sundal CollierRBCCarnegieJefferiesSEB EquitiesDNB MarketsKepler CheuvreuxNordea MarketsMorgan StanleyHSBCRBC Capital MarketsDNBHandelsbanken Capital MarketsMorningstarDanske Bank MarketsDanske BankJefferies InternationalHandelsbanken

Latest Target

+9.52%
460.00 SEK

Three Month Consensus

+14.29%
480.00 SEK

All Price Targets For Sobi

Pareto Securities
460.00 SEK
+9.52%
Berenberg
Berenberg
Feb 23
500.00 SEK
+19.05%
Nordea
Nordea
Jan 29
439.00 SEK
+4.52%
SEB
SEB
Jan 19
500.00 SEK
+19.05%
Barclays
395.00 SEK
-5.95%
Exane BNP Paribas
320.00 SEK
-23.81%
Deutsche Bank
370.00 SEK
-11.90%
DNB Carnegie
400.00 SEK
-4.76%
ABG Sundal Collier
280.00 SEK
-33.33%
RBC
RBC
Jul -25
345.00 SEK
-17.86%
Carnegie
Carnegie
Feb -25
385.00 SEK
-8.33%
Jefferies
Jefferies
Oct -24
310.00 SEK
-26.19%
SEB Equities
300.00 SEK
-28.57%
DNB Markets
335.00 SEK
-20.24%
Kepler Cheuvreux
330.00 SEK
-21.43%
Nordea Markets
340.00 SEK
-19.05%
Morgan Stanley
325.00 SEK
-22.62%
HSBC
HSBC
Feb -24
330.00 SEK
-21.43%
RBC Capital Markets
325.00 SEK
-22.62%
DNB
DNB
Oct -23
300.00 SEK
-28.57%
Handelsbanken Capital Markets
335.00 SEK
-20.24%
Morningstar
252.00 SEK
-40.00%
Danske Bank Markets
325.00 SEK
-22.62%
Danske Bank
275.00 SEK
-34.52%
Jefferies International
295.00 SEK
-29.76%
Handelsbanken
197.00 SEK
-53.10%

About The Company

Swedish Orphan Biovitrum (Sobi) is a pharmaceutical company with two focus areas: haemophilia and rare diseases. Sobi is a merger of Swedish Orphan and Biovitrum. The company has its premises in Karolinska Institutet Science Park in Solna.
Wikipedia